Last updated: June 27, 2025
[Active] Setting Research Priorities in Recurrent Pregnancy Loss
Goal: To engage individuals with lived and living experience of recurrent pregnancy loss in shaping research priorities, and to contribute to broader knowledge translation efforts that advance patient-centered research within this field.
Progress: An online public survey is open and gathering responses from those with lived experience, professionals in reproductive health, and others connected to RPL.
Early Pregnancy
- Live Birth Outcomes in Patients with Recurrent Pregnancy Loss and Asherman Syndrome
- Impact of Hereditary Thrombophilias and Thromboprophylaxis on Live Birth Outcomes in Patients with Recurrent Pregnancy Loss
- Prediction of Pregnancy Outcomes Using Point-of-Care First Trimester Biomarkers in a Recurrent Pregnancy Loss Population
- Amongst Patients with Primary Recurrent Pregnancy Loss, Do Declining Beta-hCG Values in Early Pregnancy Always Indicate a Non-Viable Pregnancy?
- Does a Declining or Plateauing Beta-hCG in Early Pregnancy Always Indicate a Non-Viable Pregnancy in Patients with Vaginal Bleeding and/or Pelvic Pain?
- Does Vaginal Bleeding Before 20 Weeks Gestation Result in Adverse Perinatal Outcomes for Women in British Columbia?
- Patient Characteristics of Subpopulations Experiencing Recurrent Pregnancy Loss: A Comparison of Spontaneous Conceptions, Euploid Embryo Transfers, and Biochemical Losses
- Reproductive Outcomes Following Fluoroscopy-Guided Hysteroscopic Lysis of Complex Uterine Adhesions
Assisted Reproductive Technology (ART)
- Impact of the COVID-19 Pandemic on Pregnancy Complications and Conceptions Resulting in Births Following Spontaneous Conception and In-Vitro Fertilization in British Columbia: A Population-Based Study
Chronic Pelvic Pain (CPP) & Endometriosis
- Factors Affecting Hormonal Therapy Ineffectiveness and Discontinuation Due to Adverse Effects in Patients with Endometriosis-Associated Pain